液化汤治疗精液不液化症临床观察

精液不液化是导致男性不育的常见原因，余采用滋阴降火的液化汤加减治疗该症，收到了较为满意的疗效，现将临床资料较完整的16例报告如下。     

液化汤治疗精液不液化症24例

精液不液化是指精液排出体外，精液粘稠度高，精液不液化，使精子发生凝集，束缚了精子的活动力，减慢或抑制精子正常通过宫颈而致不孕，是男性不育的原因之一。笔者自1995年以来运用自拟液化汤治疗24例精液不液化症，疗效满意，现报道如下。     

精液不液化症40例临床观察

笔者自1997年以来，运用自拟“强力液化汤”治疗精液不液化40例，疗效满意，报告如下。     

精液不液化症治验

精液不液化是导致男性不育的原因之一，据统计，约占男性不育病因的47％左右。所以，对此症的研究和解决，在治疗现代男性不育中有着重要的意义。多年来，笔者对精液不液化症的中医治疗，获得满意疗效。现介绍如下：     

中医药治疗精液不液化的临床观察及分析

目的：观察和分析中医药治疗精液不液化的效果.方法：选取76例精液不液化者给予中医药治疗作为试验组,另外再选取以往单纯予以西医治疗的精液不液化者70例作为对照组,同时对两组患者临床治疗效果、精子质量进行观察,对所得数据进行统计学处理分析.结果：试验组临床治疗总有效率达92.11％高于对照组（70.00％）,P＜0.05;且两组患者精子活率和精子活力相比◆P＜0.05.结论：中医药治疗精液不液化效果显著,能明显改善精子质量、提高配偶受孕率,是一种合理且有效的治疗手段,值得临床推广.     

桂枝茯苓丸加味对血瘀型黄褐斑患者血清一氧化氮的影响

目的观察桂枝茯苓丸加味治疗血瘀型黄褐斑患者的临床疗效及对患者血清一氧化氮水平的影响。方法 77例血瘀型黄褐斑患者随机分为两组,治疗组口服桂枝茯苓丸加味,对照组口服维生素C及维生素E,两组均外涂氢醌霜。治疗3月后检测两组患者血清一氧化氮水平及临床症状积分。结果治疗组治愈率34.14%,有效率87.70%,对照组治愈率11.11%,有效率55.57%,两组比较差异均有统计学意义(P0.05)。治疗组一氧化氮水平明显低于治疗前水平,两组比较差异有统计学意义(P0.05)。结论桂枝茯苓丸加味能调节一氧化氮水平,抑制酪氨酸酶活性,减少黑色素的形成,从而起到消除和减轻黄褐斑的作用。     

促育Ⅱ号治疗精液不液化100例介绍

自1994年2月～2004年8月我们运用自拟促育Ⅱ号治疗因精液不液化而致的男性不育症100例，获得较为满意的效果，现介绍如下：     

丹兰液化汤治疗湿热兼瘀型精液不液化症46例

目的观察丹兰液化汤治疗湿热兼瘀型精液不液化症的临床疗效.方法将76例中医辨证为湿热兼瘀证的精液不液化患者,随机分为治疗组(丹兰液化汤组)和对照组(西药组)进行临床观察.结果总有效率两组分别为89.13%、73.33%,经Ridit分析,在α＝0.05水平下,其95%置信区间分别为(0.769,0.935)和(0.510,0.716),治疗组与对照组无交叉重叠,说明治疗组临床疗效显著优于对照组;精液液化时间及程度积分变化比较,两组治疗前后比较,差异均有极显著意义(P＜0.01);EPS-Rt积分变化比较,两组治疗前后比较,治疗组与对照组差异均有显著意义(P＜0.01,P＜0.05).结论丹兰液化汤治疗湿热兼瘀型精液不液化症疗效确切,能改善精液液化时间及程度,改善EPS化验指标.     

李海松教授治疗精液不液化药对浅析

精液不液化症是男科的常见病,亦是导致男性不育症的重要原因之一,目前对此病的治疗尚无特效药。中医主要根据患者整体情况,应用辨证论治的方法进行治疗,效果较为满意。李海松教授认为本病的基本病机是"脾失健运为本,痰凝瘀血为标",兼夹肾虚、湿热等病理变化。李海松教授对本病辨治经验丰富,见解独到,临床上善用药对组合灵活加减治疗本病,疗效确切,现对其具体药对做一浅析,以期能够拓展本病的治疗思路。     

精液不液化的脉血康治疗分析

目的：探讨水蛭对精液不液化的治疗作用。方法：具有正常性生活而未生育患者36例,全组病例精液常规检查结果均为精液不液化或精液液化不全,全组均口服单一水蛭焙制的肠溶性胶囊-脉血康0．75mg,一日三次,服用40—50天。结果：全组病例均禁欲5天后复查精液常规,有33例占91．6％（33／36）液化时间为40～20分钟,有2例占5．5％（2／36）液化时间为50～60min,总有效率97．2％（35／36）,只有1例液化时间由精液不液化变为液化不全,占2．7％（1／36）。结论：用水蛭焙制的脉血康胶囊治疗精液不液化具有良好的疗效。     

桂枝茯苓胶囊对慢性盆腔炎患者炎症因子及临床疗效的影响

目的:探讨桂枝茯苓胶囊对慢性盆腔炎患者炎症因子及临床疗效的影响。方法:选取我院2015年2月至2016年10月收治的120例慢性盆腔炎患者进行研究,按随机数字表法将其分为研究组与对照组,对照组患者采用莫西沙星治疗,研究组患者在此基础上给予桂枝茯苓胶囊治疗,治疗3周后比较两组患者治疗效果、炎症因子改善情况及不良反应发生情况。结果:研究组患者治疗总有效率高于对照组(95.00%vs.81.67%),差异有统计学意义(χ~2=51.175,P0.05)。治疗前两组患者炎症因子水平比较差异无统计学意义(t=0.729、0.148、0.136、0.098、0.289、0.517,P0.05)。治疗后两组患者炎症因子水平均明显改善,其中研究组患者TNFα、IL-1β、IL-8低于对照组,TGFβ1、IL-4及IL-10高于对照组,差异均有统计学意义(t=14.453、8.717、5.569、22.788、9.372、8.348,P0.05)。治疗过程中,研究组无严重不良反应发生,对照组3例(5.00%)患者服药后出现恶心症状,两组患者不良反应发生率比较差异无统计学意义(χ~2=1.372,P0.05)。结论:桂枝茯苓胶囊可有效改善慢性盆腔炎患者炎症反应,临床疗效及安全性较好。     

Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases

INTRODUCTION: Colchicine is a treatment used for aphthous stomatitis but its efficacy has never been proved. We report the results of an open trial of 54 patients treated with colchicine for aphthous stomatitis. The aim of our study was to assess the long and short term efficacy and tolerance of this molecule in this disease. PATIENTS AND METHODS: The case reports of 64 patients presenting with severe, recurrent aphthous stomatitis treated with colchicine between 1986 and 2000 were analyzed retrospectively. Only immunocompetent patients exhibiting idiopathic aphthous stomatitis or Beh?et's disease were included. Ten patients were excluded: 4 cases of Beh?et's disease treated with colchicine and systemic corticosteroids, 4 cases of aphthous stomatitis secondary to a hematological cause and 2 patients who were lost to follow-up after 3 month's treatment. Colchicine was prescribed at a dose of 1 to 1.5 mg/d for at least 3 months. All the patients were assessed after 3 month's treatment and all were contacted by phone in May 2000. Our end-point criteria were: the frequency and duration of the episodes, intensity of pain and impact on the quality of life of the patients. RESULTS: Fifty-four patients were included: 39 women (mean age=44 +/- 16.8) and 15 men (mean age=49 +/- 13.5). The disease had progressed for a mean of 11.6 +/- 13.5 years. After 3 month's treatment, 12 patients (22 p. 100) no longer had aphta and were in complete remission, 22 patients (41 p. 100) were significantly improved, since the frequency and duration of the lesions had decreased by at least 50 p. 100 and the latter were no longer painful. Treatment failed or tolerance was poor in 20 patients (37 p. 100). Patients were monitored and assessed for a mean of 4.7 years (range: 6 months to 13 years). Six patients were lost to follow-up. Three patients (6 p. 100) were considered as cured, since they were still in complete remission after suspension of colchicine respectively 6, 24 and 72 months later. Fifteen patients (31 p. 100) had still improved. Among the latter, 10 continued colchicine for a mean of 27 months, and 5 patients stopped treatment, which they considered tedious, after a mean of 16 months. These 15 patients noted a significant reduction in the frequency and duration of the lesions. Moreover, the subjective end-point criteria had improved significantly for them not to wish to change treatment. Thirty patients (63 p. 100) were not improved by the treatment. Some benign adverse events were noted in 10 patients (18.5 p. 100) and led to suspension of treatment in 4 cases. DISCUSSION: This study, which is the first in size (n=54) and duration of follow-up (4.7 years), showed that colchicine is an efficient preventive treatment of severe aphthous stomatitis for 63 p. 100 of patients after 3 month's treatment and that this improvement was lasting in 37 p. 100 of them. Colchicine should therefore be proposed in first intention in severe recurrent aphthous stomatitis, since it is effective, well tolerated and easy to use.     

益肾生精丹治疗少精不育60例

目的探讨补肾生精的作用。方法以益肾生精丹(自拟)与安慰剂对照,随机分组、双盲给药的方法。结果以单纯补肾为法组成的益肾生精丹治疗少精不育60例,获痊愈18例、总有效率83.3%的良效;同时对用安慰剂的60例所做的双盲观察表明,治疗组与安慰剂组疗效有显著性差异(P<0.01)。结论补肾可生精。     

桂枝茯苓丸联合促性腺激素释放激素激动剂对围绝经期子宫肌瘤合并异常子宫出血患者血清性激素、血管生成素-2水平的影响

目的 探讨桂枝茯苓丸联合促性腺激素释放激素激动剂(GnRH-a)对围绝经期子宫肌瘤合并异常子宫出血患者血清性激素、血管生成素-2(Ang-2)水平的影响.方法 选取2018年5月至2019年6月青海大学附属医院收治的92例围绝经期子宫肌瘤合并异常子宫出血患者作为研究对象.按照随机数字表法分为治疗组(n=46例)和对照组...     

梅毒血清试验假阳性54例分析

54名献血者在中心血站作梅毒血清（ELA）试验为阳性,但经病史询问与体格检查均不支持梅毒诊断,故肯定其血清试验为假阳性。     

急诊内科昏迷患者54例临床分析

目的 本研究对急诊内科昏迷患者的临床特点、临床检查结果进行分析,探讨恰当的治疗方法,为提高急诊内科昏迷患者的急诊救治成功率提供一定的参考.方法 选择武警总医院本院急诊科2011年3月～2011年12月收治的54例内科昏迷患者,男31例,女23例,对患者的临床诊断及治疗过程进行分析.结果 本组患者治疗成功51例,死亡3例,死亡原因包括肺部感染、肾衰竭、颅内感染等.治疗前后根据格拉斯哥评分法(GCS)对患者昏迷状况进行评价,治疗后54例患者浅昏迷28例,中度昏迷18例,深昏迷8例,与治疗前相比有显著的改善(P＜0.05).结论 对急诊内科昏迷患者应首先进行及时的治疗,防止发生脑部或者重要脏器持续性受损,并通过全面的检查、询问病史明确发病原因,密切观察患者病情,避免病情恶化,挽救患者的生命,保证患者的生命质量.     

泽桂癃爽胶囊治疗Ⅲ型前列腺炎124例

根据1998年国际前列腺炎合作网络(IPCN)调查并确定的NIH分类法,Ⅲ型前列腺炎即慢性非细菌性前列腺炎(Chronic nonbacterial prostatitis,CNP)/慢性骨盆疼痛综合征(Chronic pelvic pain syndromes,CPPS),也就是过去分类的慢性非细菌性前列腺炎和前列腺痛。患者的主要临床表现为盆腔区域的疼痛或不适至少持续3个月以上,可伴随各种排尿和性生活方面症状,但没有反复的尿道感染(Urinary tract infections,UTIs)病史,实验室检查不能证实感染的存在[1]。此类患者发病率高,好发于中青年,发病机制仍未阐明,临床治疗较为困难。我科自2003年9月…     

三金片、金匮肾气丸联合抗生素治疗老年慢性前列腺炎临床观察

目的：观察三金片、金匮肾气丸联合抗生素治疗老年慢性前列腺炎临床疗效。方法：门诊慢性前列腺炎患者随机分为两组：抗生素治疗组（52例）,给予左氧氟沙星片与罗红霉素片口服;联合治疗组（56例）,给予三金片、金匮肾气丸与左氧氟沙星、罗红霉素同时口服治疗。连续治疗30d观察疗效和NIH—CPSI积分。结果：两组临床疗效总有效率、愈显率比较P〈0．05;两组治疗后NIH—CPSI积分均较治疗前有不同程度的改善P〈0．01,联合治疗组改善更明显P〈0．05。结论：三金片、金匮肾气丸联合抗生素治疗老年慢性前列腺炎安全有效。